FDA Inspection 1228746 — Lim Lay Ah Young
The FDA completed an inspection of Lim Lay Ah Young on Jan 19, 2024 in Minato. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Minato (Japan)
Additional Details
Clinical BA/BE